Pharma Foods International Co., Ltd. (2929) Stock Price & News

2929:TYO

Pharma Foods International Co., Ltd.

¥564.00

-0.18%

(-1.00) 1D

Nov 13, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 2929...

Open

¥565

High

¥570

Low

¥560

Mkt. cap

16.40B

Avg. vol.

183.59K

Volume

112.40K

Dividend

4.43%

Quarterly dividend

¥6

Ex-dividend date

Jul 30, 2026

P/E ratio

8.22

52-wk high

¥823

52-wk low

¥513

EPS

¥69

Shares outstanding

29.03M

No. of employees

625

Open

¥565

High

¥570

Low

¥560

Mkt. cap

16.40B

Avg. vol.

183.59K

Volume

112.40K

Dividend

4.43%

Quarterly dividend

¥6

Ex-dividend date

Jul 30, 2026

P/E ratio

8.22

52-wk high

¥823

52-wk low

¥513

EPS

¥69

Shares outstanding

29.03M

No. of employees

625

Related stocks

Japan Eyewear Holdings Co Ltd

News stories

From web sources and news partners

TradingKey

7 hours ago

S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months

Foreign Policy Journal

6 hours ago

Dow Jones Industrial Average (DJIA) Stays Green While Nasdaq Tumbles Nearly 1% In Sharp Rotation Trade

24/7 Wall St.

10 hours ago

He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076

Traders Union

14 hours ago

Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance

About Pharma Foods International Co., Ltd.

CEO-

Employees625

FoundedSep 12, 1997

Headquarters-

SectorHealth Care

IndustryBiotechnology

Websitepharmafoods.co.jp

All values in JPY	Oct 2025	Jan 2026	Apr 2026	Jul 2026
Revenue	15.71B	16.73B	16.11B	14.67B
Cost of goods sold	3.08B	3.06B	3.21B	3.17B
Cost of revenue	3.08B	3.06B	3.21B	3.17B
Research and development expenses	332.00M	359.00M	425.00M	742.00M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	14.80B	13.15B	11.54B	6.68B
Operating expense	15.14B	13.52B	11.97B	7.44B
Total operating expenses	18.22B	16.58B	15.18B	10.61B
Operating income	-2.51B	149.00M	931.00M	4.06B
Other non operating income	-131.00M	73.00M	31.00M	142.00M
EBT including unusual items	-2.64B	90.00M	893.00M	3.98B
EBT excluding unusual items	-2.65B	212.00M	895.00M	3.98B
Income tax expense	-749.00M	23.00M	130.00M	934.00M
Effective tax rate	28.37%	25.56%	14.56%	23.45%
Other operating expenses	-	-	-	-
Net income	-1.89B	67.00M	763.00M	3.05B
Net profit margin	-12.04%	0.40%	4.74%	20.79%
Earnings per share	-	-	-	-
Interest and investment income	10.00M	17.00M	9.00M	21.00M
Interest expense	-25.00M	-34.00M	-49.00M	-53.00M
Net interest expenses	-15.00M	-17.00M	-40.00M	-32.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	-2.34B	327.00M	1.12B	4.26B
Gain or loss from assets sale	-4.00M	-	-	-117.00M

Finance

Ask anything